#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Myxoid liposarcoma Multifocal motor neuropathy Hereditary motor and sensory neuropathy Endometrial cancer Pemphigoid Fungal infection Chronic lymphocytic leukaemia recurrent Mantle cell lymphoma refractory Plasma cell myeloma refractory Non-Hodgkin's lymphoma refractory Enteritis Ductal adenocarcinoma of pancreas Chronic lymphocytic leukaemia refractory Liposarcoma recurrent Duchenne muscular dystrophy gene carrier More trials…

    Learn about Rare Diseases

    Angiosarcoma – Basic Information Glycogen storage disease type V – Life with Disease Epidermolysis bullosa – Treatment Waldenstrom’s macroglobulinaemia recurrent – Diagnostics Chondrosarcoma – Trials in Disease Cholangitis sclerosing – Life with Disease Synovial sarcoma recurrent – Life with Disease Testicular leiomyosarcoma – Trials in Disease Burkitt’s lymphoma – Diagnostics Immunodeficiency congenital – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cart45Ra-Nkg2D Cells Mps-214 Gs-5245 Av-Ec2023 Toripalimab Cilazapril Benzylpenicillin Darbepoetin Alfa Morphine Hydrochloride Remestemcel Dimeticone Specific Nucleic Acid Sna-Xfsa Berzosertib Esketamine Pantothenate Sodium Riluzole Tolinapant Lactate Glucagon Dapagliflozin Propanediol SODIUM HYDROXIDE More therapies…

    Learn about Your Condition

    Myofascial pain syndrome Choroidal neovascularisation Extraskeletal ossification Labour pain Rectal cancer stage II Brain stem glioma Metastases to liver Hydrocephalus Acoustic neuroma Device related infection Plasmablastic lymphoma Spinal pain Pulmonary hypertension Skin papilloma Autoimmune hepatitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Friedreich’s ataxia

  • Study to evaluate the effect of omaveloxolone on mitochondrial function in patients with Friedreich’s ataxia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Friedreich’s ataxia
    Investigated Drugs:
    • Omaveloxolone
    Czechia Poland

  • A study testing omaveloxolone compared to placebo for children and adolescents aged 2 to 15 years with Friedreich’s ataxia

    Recruiting

    3 1
    Investigated Drugs:
    • Omaveloxolone
    Austria Denmark France Germany Ireland Italy +2

  • Long-term safety and effectiveness study of vatiquinone (oral capsules) in patients with Friedreich ataxia who have previously received this treatment

    Recruiting

    3 1 1
    Investigated Diseases:
    • Friedreich’s ataxia
    Investigated Drugs:
    • Vatiquinone
    France Germany Italy Spain

  • A Phase 3 Study Evaluating the Efficacy and Safety of Subcutaneous Nomlabofusp in Adults and Children with Friedreich’s Ataxia

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Friedreich’s ataxia
    France

  • A Phase 2 Study to Evaluate Safety and Effectiveness of Omaveloxolone (RTA 408) in Patients with Friedreich’s Ataxia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Friedreich’s ataxia
    Investigated Drugs:
    • Omaveloxolone
    Austria Italy

  • Study on the Effects of Dimethyl Fumarate for Patients with Friedreich’s Ataxia

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Friedreich’s ataxia
    Investigated Drugs:
    • Dimethyl Fumarate
    Italy

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!